Neumora Therapeutics, Inc. (NMRA) — Institutional Holders, Q2 2026 (page 2)
113 institutional investment managers reported a NMRA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $129.2M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 113. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
NMRA 13F holders ranked 101–113 of 113
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 101 | NISA INVESTMENT ADVISORS#101 · 1,466 sh | 1,466 | $2.5K | — | 0.0% |
| 102 | State of Wyoming#102 · 1,333 sh | 1,333 | $2.3K | <0.01% | New |
| 103 | Physician Wealth Advisors#103 · 1,320 sh | 1,320 | $2.2K | — | 0.0% |
| 104 | PNC FINANCIAL SERVICES GROUP#104 · 1,000 sh | 1,000 | $1.7K | 0.00% | 0.0% |
| 105 | Sterling Capital Management#105 · 360 sh | 360 | $612.00 | — | New |
| 106 | Parallel Advisors#106 · 279 sh | 279 | $474.00 | 0.00% | 0.0% |
| 107 | Caitong International Asset Management , Ltd#107 · 260 sh | 260 | $442.00 | <0.01% | +1138.1% |
| 108 | Optiver Holding B.V.#108 · 200 sh | 200 | $340.00 | 0.00% | New |
| 109 | SRS Capital Advisors#109 · 144 sh | 144 | $245.00 | 0.00% | New |
| 110 | Quarry#110 · 55 sh | 55 | $94.00 | 0.00% | New |
| 111 | SBI Securities , Ltd.#111 · 20 sh | 20 | $34.00 | — | +11.1% |
| 112 | Capital Advisors, Ltd.#112 · 145 sh | 145 | $0.00 | 0.00% | 0.0% |
| 113 | Centerpoint Advisors#113 · 220 sh | 220 | $0.00 | 0.00% | 0.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.